Trial Condition(s):

Postmenopause, Hypertension, Pre-Hypertension

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

Bayer Identifier:

91507

ClinicalTrials.gov Identifier:

NCT00420342

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The main purpose of this study is to compare the effects of treatment of two different formulations of Angeliq® and Prempro on blood pressure in post-menopausal women with prehypertension.

Inclusion Criteria
- Postmenopausal women 45 - 65 years old with prehypertension
Exclusion Criteria
- Hormone therapy (estrogen/progestin)

Trial Summary

Enrollment Goal
92
Trial Dates
black-arrow
Phase
2
Could I receive a placebo?
No
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Medical Center for Clinical Research

San Diego, United States, 92108

Status
Completed
 
Locations

University of Miami

Miami, United States, 33136

Status
Completed
 
Locations

Clinical Research of Philadelphia, LLC

Philadelphia, United States, 19114

Status
Completed
 
Locations

Atlantic Institute of Clinical Research

Daytona Beach, United States, 32114

Status
Completed
 
Locations

Marin Endocrine Associates

Greenbrae, United States, 94904

Status
Completed
 
Locations

Dr. Yekaterina Khronusova, MD

Las Vegas, United States, 89122

Status
Completed
 
Locations

South Carolina Clinical Research Center

Columbia, United States, 29201

Status
Completed
 
Locations

Millennium Clinical Research Center

Arlington, United States, 22203

Status
Completed
 
Locations

Women's Health Care Specialist

Paw Paw, United States, 49079

Status
Completed
 

Trial Design